News Daily News AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More Shelley Wood December 17, 2020
News Daily News Knowing Comorbidities, Medication Use May Save Lives in COVID-19 Michael O'Riordan December 15, 2020
News Conference News AHA 2020 Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials Michael O'Riordan November 17, 2020
News Conference News EAS 2020 Inclisiran Effective Across FH Genotypes, as Well as in Primary Prevention Michael O'Riordan October 08, 2020
News Daily News VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks Michael O'Riordan September 24, 2020
News Daily News ABC-Bleeding Score Stratifies Risk in A-fib Patients on OAC and Aspirin Todd Neale September 21, 2020
News Conference News Blood Pressure Insights in COVID-19: Watch for Drops and RAAS Red Flags L.A. McKeown September 10, 2020
News Conference News ESC 2020 Antihypertensives Cut CV Events Across BP Levels, Regardless of Prior CVD: BPLTTC Shelley Wood August 31, 2020
News Daily News New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts Michael O'Riordan August 06, 2020
News Daily News Rosuvastatin-Canagliflozin Combo May Be Toxic, Case Suggests Todd Neale August 03, 2020
News Daily News Higher Risk of HF After ACS for Women Previously on Beta-blockers Michael O'Riordan July 16, 2020
News Daily News Heart, Kidneys, Brain, and More: COVID-19’s Wide-ranging Effects Michael O'Riordan July 13, 2020
News Daily News Statins Cut CV Risk but Don’t Boost Disability-Free Survival in Healthy Elderly Michael O'Riordan July 06, 2020
News Features Hospitals Plan Cautious Restart to Elective Procedures as COVID-19 Wanes Michael O'Riordan May 12, 2020
News Daily News COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk Michael O'Riordan May 05, 2020
News Conference News ACC 2020 Pooled Inclisiran Data: Safe LDL-Lowering, Plus Hints of Fewer CVD Events Michael O'Riordan April 02, 2020